Terminated PHASE3 INTERVENTIONAL 1-arm NCT00993785

CoStar Catheter System Evaluation (CONCISE)

Sponsor: Conor Medsystems

Conditions Symptomatic Ischemic Heart Disease

Interventions Costar Coronary Stent Delivery System

Updated 5 times since 2017 Last updated: Oct 27, 2009 Started: Feb 28, 2007 Completion: Apr 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

CoStar Stent IDE failed to meet primary endpoint

Other terminated trials from Conor Medsystems

See all terminations from Conor Medsystems

Listed as NCT00993785, this PHASE3 trial focuses on Symptomatic Ischemic Heart Disease and remains terminated or withdrawn. Sponsored by Conor Medsystems, it has been updated 5 times since 2007, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Conor Medsystems

Data source: Conor Medsystems

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Am Kurpark 1, Germany